Discoidin domain receptor (DDR) was a collagen-activated receptor tyrosine kinase and has become an attractive target for anticancer therapy given its involvement in tumor growth, metastasis development, and tumor dormancy (Mehta et al., 2021). This evidence concerns the gene DDR1 and neoplasm.